New GLP-1 pill helps patients lose up to 8% of body weight, trial shows
Story summaryOrforglipron led to greater weight loss than semaglutide tablets and could offer more effective oral alternative to jabs
Read at Guardian AustraliaOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.